RELATIONSHIP BETWEEN PATIENT CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH MULTIPLE MYELOMA

被引：0
|
作者：
Gonzalez-McQuire, S. [1 ]
Hensen, M. [2 ]
Spoorendonk, J. [2 ]
Alleman, C. [2 ]
机构：
[1] Amgen Europe GmbH, Zug, Switzerland
[2] Pharmerit BV, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2407
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY23
引用
收藏
页码：A662 / A662
页数：1
相关论文
共 50 条
  • [41] The Relationship Between Multiple Myeloma and Hypogonadism: A Systematic Review
    Roth, B.
    Hammad, M.
    Sanford, D.
    Barham, D.
    Yafi, F.
    Jenkins, L.
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [42] A RAPID LITERATURE REVIEW OF REAL-WORLD EVIDENCE IN MULTIPLE MYELOMA: PATIENT CHARACTERISTICS AND HEALTH OUTCOMES
    Farris, M.
    White, K.
    Liu, F. F.
    Cowling, T.
    VALUE IN HEALTH, 2018, 21 : S464 - S464
  • [43] Clinical characteristics of patients with relapsed multiple myeloma
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Niesvizky, Ruben
    Palumbo, Antonio
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 827 - 835
  • [44] "Routine assessment of patient-reported outcomes (PROs) in patients with multiple myeloma" An analysis of the Austrian Myeloma Registry (AMR)
    Weger, R.
    Willenbacher, W.
    Loth, F.
    Willenbacher, E.
    Blazek, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 159 - 159
  • [45] Examining Treatment Patterns, Patient Characteristics, and Outcomes Associated With Pomalidomide in Multiple Myeloma Following Lenalidomide Therapy
    Bonafede, Machaon
    Nelson, James
    Clancy, Zoe
    Copher, Ronda
    Mark, Tomer
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E269 - E269
  • [46] Relationship between Circulating BAFF Serum Levels with Proliferating Markers in Patients with Multiple Myeloma
    Alexandrakis, Michael G.
    Roussou, Parascevi
    Pappa, Constantina A.
    Messaritakis, Ippokratis
    Xekalou, Athina
    Goulidaki, Nektaria
    Boula, Anna
    Tsirakis, George
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [47] Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma
    Zhang, Zhi-yao
    Li, Yan-chen
    Geng, Chuan-ying
    Wang, Hui-juan
    Chen, Wen-ming
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [48] The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myeloma
    Scudla, Vlastimil
    Ordeltova, Marta
    Bacovsky, Jaroslav
    Vytrasova, Marketa
    Horak, Pavel
    Minarik, Jiri
    HAEMATOLOGICA, 2005, 90 (12) : 1713 - 1714
  • [49] Assessment tools for patient-reported outcomes in multiple myeloma
    Ting Wang
    Qin Lu
    LeiWen Tang
    Supportive Care in Cancer, 2023, 31
  • [50] Multiple myeloma: patient outcomes in real-world practice
    Yong, Kwee
    Delforge, Michel
    Driessen, Christoph
    Fink, Leah
    Flinois, Alain
    Gonzalez-McQuire, Sebastian
    Safaei, Reza
    Karlin, Lionel
    Mateos, Maria-Victoria
    Raab, Marc S.
    Schoen, Paul
    Cavo, Michele
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (02) : 252 - 264
12345